GPR56 may have multiple downstream effects on melanoma cells apart from its inhibition on cell–ECM signaling, so we sought to directly determine if the cell–ECM signaling inhibition by GPR56 is causative for its impediment on lung metastases. The gene discussed is ADGRG1; the disease is melanoma.